|
83
|
275
|
6q3kA |
Engineered human hla_a2 mhc class i molecule in complex with nv9 peptide |
|
0
|
9
|
6ewcG |
Crystal structure of non-phosphorylated form of rls phosphopeptide bound to hla-a2 in complex with lilrb1 |
|
0
|
9
|
6ewaG |
Crystal structure of hla-a2 in complex with lilrb1 |
|
0
|
9
|
3fqtC |
Phosphorylation of self-peptides alters human leukocyte antigen class i-restricted antigen presentation and generates tumor specific epitopes |
|
0
|
9
|
3fqxC |
Phosphorylation of self-peptides alters human leukocyte antigen class i-restricted antigen presentation and generates tumor specific epitopes |
|
0
|
9
|
4l29n |
Structure of wtmhc class i with ny-eso1 double mutant |
|
0
|
9
|
5eu5C |
Hla class i antigen |
|
0
|
9
|
3fquC |
Phosphorylation of self-peptides alters human leukocyte antigen class i-restricted antigen presentation and generates tumor specific epitopes |
|
0
|
10
|
3fqnC |
Phosphorylation of self-peptides alters human leukocyte antigen class i-restricted antigen presentation and generates tumor specific epitopes |
|
0
|
9
|
3fqwC |
Phosphorylation of self-peptides alters human leukocyte antigen class i-restricted antigen presentation and generates tumor specific epitopes |
|
0
|
9
|
2c7uF |
Conflicting selective forces affect cd8 t-cell receptor contact sites in an hla-a2 immunodominant hiv epitope. |
|
0
|
9
|
2x4oF |
Crystal structure of mhc class i hla-a2.1 bound to hiv-1 envelope peptide env120-128 |
|
0
|
9
|
4k7fF |
Newly identified epitope v60 from hbv core protein complexed with hla-a*0201 |
|
0
|
9
|
1tvhC |
Crystal structure of modified melanoma antigen gp100(209-t2m) bound to human class i mhc hla-a2 |
|
0
|
9
|
1tvbC |
Crystal structure of melanoma antigen gp100(209-217) bound to human class i mhc hla-a2 |
|
0
|
9
|
5eu3C |
Hla class i antigen |
|
0
|
9
|
5eu6C |
Hla class i antigen |
|
0
|
10
|
5c0iC |
Hal-a02 carrying rqfgpdfpti |
|
0
|
10
|
5c0eC |
Hla-a02 carrying ylggpdfpti |
|
0
|
10
|
5c09C |
Hla class i histocompatibility antigen |
|
73
|
276
|
6ewaA |
Crystal structure of hla-a2 in complex with lilrb1 |
|
76
|
276
|
6ewoA |
Crystal structure of non-phosphorylated form of rtf phosphopeptide bound to hla-a2 in complex with lilrb1 |
|
70
|
276
|
6eqaA |
Hla class i histocompatibility antigen |
|
36
|
196
|
6eqbD |
Hla class i histocompatibility antigen |
|
35
|
195
|
6ewcD |
Crystal structure of non-phosphorylated form of rls phosphopeptide bound to hla-a2 in complex with lilrb1 |
|
15
|
99
|
6ewcB |
Crystal structure of non-phosphorylated form of rls phosphopeptide bound to hla-a2 in complex with lilrb1 |
|
30
|
194
|
6eqaD |
Hla class i histocompatibility antigen |
|
13
|
99
|
6ewaB |
Crystal structure of hla-a2 in complex with lilrb1 |
|
52
|
244
|
6eqaE |
Hla class i histocompatibility antigen |
|
62
|
276
|
6eqbA |
Hla class i histocompatibility antigen |
|
15
|
99
|
6ewoB |
Crystal structure of non-phosphorylated form of rtf phosphopeptide bound to hla-a2 in complex with lilrb1 |
|
34
|
195
|
6ewoD |
Crystal structure of non-phosphorylated form of rtf phosphopeptide bound to hla-a2 in complex with lilrb1 |
|
31
|
195
|
6ewaD |
Crystal structure of hla-a2 in complex with lilrb1 |
|
71
|
276
|
6ewcA |
Crystal structure of non-phosphorylated form of rls phosphopeptide bound to hla-a2 in complex with lilrb1 |
|
68
|
276
|
6g3jA |
Mhc a02 allele presenting mtsaigilvp |
|
0
|
10
|
6g3jC |
Mhc a02 allele presenting mtsaigilvp |
|
16
|
100
|
6g3jB |
Mhc a02 allele presenting mtsaigilvp |
|
15
|
102
|
5iroD |
Crystal structure of a complex between the human adenovirus type 4 e3-19k protein and mhc class molecule hla-a2/tax |
|
75
|
275
|
6dkpA |
The complex among dmf5(alpha-d26y, alpha-y50a,beta-l98w) tcr, human class i mhc hla-a2 and mart-1(26-35)(a27l) peptide |
|
41
|
199
|
6dkpD |
The complex among dmf5(alpha-d26y, alpha-y50a,beta-l98w) tcr, human class i mhc hla-a2 and mart-1(26-35)(a27l) peptide |
|
15
|
100
|
6d78B |
The complex between high-affinity tcr dmf5(alpha-d26y,beta-l98w) and human class i mhc hla-a2 with the bound mart-1(27-35)peptide |
|
63
|
240
|
6d78E |
The complex between high-affinity tcr dmf5(alpha-d26y,beta-l98w) and human class i mhc hla-a2 with the bound mart-1(27-35)peptide |
|
61
|
242
|
6dkpE |
The complex among dmf5(alpha-d26y, alpha-y50a,beta-l98w) tcr, human class i mhc hla-a2 and mart-1(26-35)(a27l) peptide |
|
17
|
99
|
6dkpB |
The complex among dmf5(alpha-d26y, alpha-y50a,beta-l98w) tcr, human class i mhc hla-a2 and mart-1(26-35)(a27l) peptide |
|
43
|
199
|
6d78D |
The complex between high-affinity tcr dmf5(alpha-d26y,beta-l98w) and human class i mhc hla-a2 with the bound mart-1(27-35)peptide |
|
79
|
275
|
6d78A |
The complex between high-affinity tcr dmf5(alpha-d26y,beta-l98w) and human class i mhc hla-a2 with the bound mart-1(27-35)peptide |
|
57
|
241
|
5iszE |
Crystal structure of ls01-tcr/m1-hla-a*02 complex |
|
34
|
200
|
5iszD |
Crystal structure of ls01-tcr/m1-hla-a*02 complex |
|
15
|
98
|
5iszB |
Crystal structure of ls01-tcr/m1-hla-a*02 complex |
|
13
|
100
|
6eqbB |
Hla class i histocompatibility antigen |
